Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

412 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development of an umbilical cord blood transplantation-specific nonrelapse mortality risk assessment score.
Okada Y, Usui Y, Hayashi H, Nishikubo M, Toubai T, Uchida N, Tanaka M, Onizuka M, Takahashi S, Doki N, Uehara Y, Maruyama Y, Ishiwata K, Kawakita T, Sawa M, Eto T, Ishimaru F, Kato K, Fukuda T, Atsuta Y, Kanda J, Yakushijin K, Nakasone H. Okada Y, et al. Among authors: onizuka m. Blood Adv. 2024 Mar 26;8(6):1359-1368. doi: 10.1182/bloodadvances.2023011837. Blood Adv. 2024. PMID: 38163321 Free PMC article.
Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia.
Atsuta Y, Suzuki R, Nagamura-Inoue T, Taniguchi S, Takahashi S, Kai S, Sakamaki H, Kouzai Y, Kasai M, Fukuda T, Azuma H, Takanashi M, Okamoto S, Tsuchida M, Kawa K, Morishima Y, Kodera Y, Kato S; Japan Cord Blood Bank Network. Atsuta Y, et al. Blood. 2009 Feb 19;113(8):1631-8. doi: 10.1182/blood-2008-03-147041. Epub 2008 Dec 22. Blood. 2009. PMID: 19104080 Free article. Clinical Trial.
Allogeneic stem cell transplantation for adult Philadelphia chromosome-negative acute lymphocytic leukemia: comparable survival rates but different risk factors between related and unrelated transplantation in first complete remission.
Nishiwaki S, Inamoto Y, Sakamaki H, Kurokawa M, Iida H, Ogawa H, Fukuda T, Ozawa Y, Kobayashi N, Kasai M, Mori T, Iwato K, Yoshida T, Onizuka M, Kawa K, Morishima Y, Suzuki R, Atsuta Y, Miyamura K. Nishiwaki S, et al. Among authors: onizuka m. Blood. 2010 Nov 18;116(20):4368-75. doi: 10.1182/blood-2010-02-269571. Epub 2010 Jul 27. Blood. 2010. PMID: 20664060 Free article.
Recipient PTPN22 -1123 C/C genotype predicts acute graft-versus-host disease after HLA fully matched unrelated bone marrow transplantation for hematologic malignancies.
Espinoza JL, Takami A, Onizuka M, Morishima Y, Fukuda T, Kodera Y, Akiyama H, Miyamura K, Mori T, Nakao S; Japan Marrow Donor Program. Espinoza JL, et al. Among authors: onizuka m. Biol Blood Marrow Transplant. 2013 Feb;19(2):240-6. doi: 10.1016/j.bbmt.2012.09.014. Epub 2012 Sep 28. Biol Blood Marrow Transplant. 2013. PMID: 23025987 Free article.
Pretransplant administration of imatinib for allo-HSCT in patients with BCR-ABL-positive acute lymphoblastic leukemia.
Mizuta S, Matsuo K, Nishiwaki S, Imai K, Kanamori H, Ohashi K, Fukuda T, Onishi Y, Miyamura K, Takahashi S, Onizuka M, Atsuta Y, Suzuki R, Morishima Y, Kato K, Sakamaki H, Tanaka J. Mizuta S, et al. Among authors: onizuka m. Blood. 2014 Apr 10;123(15):2325-32. doi: 10.1182/blood-2013-11-538728. Epub 2014 Mar 3. Blood. 2014. PMID: 24591204 Free article.
Biological significance of HLA locus matching in unrelated donor bone marrow transplantation.
Morishima Y, Kashiwase K, Matsuo K, Azuma F, Morishima S, Onizuka M, Yabe T, Murata M, Doki N, Eto T, Mori T, Miyamura K, Sao H, Ichinohe T, Saji H, Kato S, Atsuta Y, Kawa K, Kodera Y, Sasazuki T; Japan Marrow Donor Program. Morishima Y, et al. Among authors: onizuka m. Blood. 2015 Feb 12;125(7):1189-97. doi: 10.1182/blood-2014-10-604785. Epub 2014 Dec 17. Blood. 2015. PMID: 25519752 Free PMC article.
A donor thrombomodulin gene variation predicts graft-versus-host disease development and mortality after bone marrow transplantation.
Nomoto H, Takami A, Espinoza JL, Matsuo K, Mizuno S, Onizuka M, Kashiwase K, Morishima Y, Fukuda T, Kodera Y, Doki N, Miyamura K, Mori T, Nakao S, Ohtake S, Morishita E. Nomoto H, et al. Among authors: onizuka m. Int J Hematol. 2015 Oct;102(4):460-70. doi: 10.1007/s12185-015-1852-7. Epub 2015 Aug 6. Int J Hematol. 2015. PMID: 26246110 Clinical Trial.
Clinical significance of high-dose cytarabine added to cyclophosphamide/total-body irradiation in bone marrow or peripheral blood stem cell transplantation for myeloid malignancy.
Arai Y, Aoki K, Takeda J, Kondo T, Eto T, Ota S, Hashimoto H, Fukuda T, Ozawa Y, Kanda Y, Kato C, Kurokawa M, Iwato K, Onizuka M, Ichinohe T, Atsuta Y, Takami A; AML and MDS Working Group of Japan Society for Hematopoietic Cell Transplantation. Arai Y, et al. Among authors: onizuka m. J Hematol Oncol. 2015 Sep 4;8:102. doi: 10.1186/s13045-015-0201-x. J Hematol Oncol. 2015. PMID: 26337829 Free PMC article.
Erratum to: A donor thrombomodulin gene variation predicts graft-versus-host disease development and mortality after bone marrow transplantation.
Nomoto H, Takami A, Espinoza JL, Matsuo K, Mizuno S, Onizuka M, Kashiwase K, Morishima Y, Fukuda T, Kodera Y, Doki N, Miyamura K, Mori T, Nakao S, Ohtake S, Morishita E. Nomoto H, et al. Among authors: onizuka m. Int J Hematol. 2015 Oct;102(4):507-8. doi: 10.1007/s12185-015-1867-0. Int J Hematol. 2015. PMID: 26351240 No abstract available.
Genome-wide surveillance of mismatched alleles for graft-versus-host disease in stem cell transplantation.
Sato-Otsubo A, Nannya Y, Kashiwase K, Onizuka M, Azuma F, Akatsuka Y, Ogino Y, Satake M, Sanada M, Chiba S, Saji H, Inoko H, Kennedy GC, Yamamoto K, Morishima S, Morishima Y, Kodera Y, Sasazuki T, Ogawa S; Japan Marrow Donor Program. Sato-Otsubo A, et al. Among authors: onizuka m. Blood. 2015 Dec 17;126(25):2752-63. doi: 10.1182/blood-2015-03-630707. Epub 2015 Oct 2. Blood. 2015. PMID: 26432889 Free article.
412 results